Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05651620 · ClinicalTrials.gov registry record
The CALERIE™ Legacy Study
A clinical trial of Calorie Restriction, sponsored by Tufts University.
- Active
- Registry status
- 216
- Enrollment target
- 3
- Study locations
NCT05651620: Active study of Calorie Restriction, sponsored by Tufts University.
NCT05651620 is a study of Calorie Restriction that is active but no longer recruiting, run by Tufts University. The registered enrollment target is 216 participants. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05651620, a study of Calorie Restriction, is active but no longer recruiting, sponsored by Tufts University.
- ACTIVE NOT RECRUITING
- Registry status
- 216 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of the CALERIE Legacy Study is to follow up on the health and wellness of participants from phase 2 of the Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) trial, which was conducted from 2007 to 2011.
Primary Outcome
Biological age will be quantified by the Klemera-Doubal Method (KDM), an algorithm-based measure. Biological age is expressed in years.
Conditions Studied
Study Locations (3)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Massachusetts
- Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University - Boston
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2023-04-06 |
| Est. Completion | 2027-01-31 |
What the registry record for NCT05651620 still lists
NCT05651620 is an observational study that tracks outcomes without assigning an intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Calorie Restriction appearing as the primary indexed condition, and to 0 interventions.
NCT05651620 reports a single indexed study location in Louisiana, Massachusetts, Missouri.
Frequently Asked Questions
What is clinical trial NCT05651620 about?
NCT05651620 is a clinical study titled "The CALERIE™ Legacy Study". The purpose of the CALERIE Legacy Study is to follow up on the health and wellness of participants from phase 2 of the Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) trial, which was conducted from 2007 to 2011.
What is the current status of trial NCT05651620?
This trial is currently active not recruiting. The enrollment target is 216 participants. The study started on 2023-04-06. Estimated completion is 2027-01-31.
What conditions does trial NCT05651620 study?
This clinical trial studies the following conditions: Calorie Restriction.
Who is sponsoring clinical trial NCT05651620?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05651620 being conducted?
This trial has 3 study locations across Louisiana, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI